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Introduction 
Free  radicals  generated  mainly  from  mitochondria 
induce oxidative stress, being involved in pathogenesis 
of  several  organ  diseases.  In  the  central  nervous 
system,  oxidative  stress  was  found  to  be  associated 
with  a  lot  of  brain  disorders  such  as,  depression,
1 
mental disorders due to severe life stress,
2 Parkinson’s 
and  Alzheimer’s  diseases.
3,4  In  addition,  oxidative 
stress  is  a  well-documented  cause  of  tissue  damages 
leading to aging.
5 Oxidative stress also hypothesized to 
lie  in  the  upstream  of  neurodegenerative  processes 
ending in Parkinson’s and Alzheimer’s diseases during 
normal life time.
6 
Angiotensin  converting  enzyme  (ACE)  inhibitors  are 
common drugs used in treatment of hypertension and 
heart  failure.  They  reduced  high  blood  pressure  and 
vascular resistance by decreasing angiotensin II (Ang 
II) production.
7 Due to the existence of a unique renin-
angiotensin system in the  brain, ACE inhibitors  have 
recently revealed neuroprotective effects in the central 
nervous system disorders including neurodegenerative 
diseases.
8-10 In some tissues including the brain, it has 
been found that ACE inhibitors interfere with oxidative 
damages induced experimentally.
11,12 However, to date 
it  is  not  clear  if  the  oxidative  status  under  normal 
circumstances can also be affected by ACE inhibitors. 
Chronically  administration  of  ACE  inhibitors 
demonstrated  through  unknown  mechanism  an 
improvement  in  learning  and  memory  of  rats.
13 
Considering  the  unknown  mechanisms  of  ACE  on 
improvement of  physiologic behavioral  functions  like 
learning and memory,
13 together with the existence of 
oxidative stress in the upstream of neurodegenerative 
processes  leading  to  aging,
5  Alzheimer’s  and 
Parkinson’s diseases,
6 this study aimed to evaluate the 
basal  oxidative  status  and  anti-oxidant  defense  of 
neuronal tissue under ACE inhibition. For this purpose, 
we  chronically  administered  different  doses  of 
perindopril  to  adult  male  rats  and  analyzed  the 
oxidative parameters in their hippocampus. 
 
Materials and Methods 
Chemicals 
Tricloroacetic acid (TCA), 2,3 thiobarbitoric acid (TBA), 
1, 1, 3, 3-tetraethoxy propane (TEP), Coomassie brilliant 
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Purpose:  Oxidative  stress  and  renin-  angiotensin  system  are  both  involved  in  the 
pathophysiology  of  most  of  the  systemic  and  central  disorders  as  well  as  in  aging. 
Angiotensin converting enzyme (ACE) inhibitors, well known for their cardiovascular 
beneficial effects, have also shown antioxidant properties in pathologic conditions. This 
study aimed to evaluate the central effect of ACE inhibitors on oxidative status under no 
pathologic condition. 
Methods: Adult male rats were divided into four groups of 9 rats each. Groups were 
treated orally by perindopril at the doses of 1, 2, 4 mg/kg/day or normal saline as the 
control for four consecutive weeks. At the end of the treatment period the reduced and 
oxidized glutathione (GSH and GSSG respectively) and malondialdehyde (MDA), the 
product of lipid peroxidation, were measured in the rats’ hippocampus. 
Results: The GSH  increased dose dependently  and was significantly  higher in the  2 
mg/kg perindopril treated group than the control group (p<0.05) while the GSSG level 
remained unchanged. As a consequent, the ratio of GSH to GSSG increased significantly 
in a dose dependent manner. There was not any significant change in MDA.  
Conclusion:  This  study  demonstrated  that  ACE  inhibition  may  cause  an  increase  in 
GSH as an anti- oxidant defense in the hippocampus. 
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blue G-250, bovine serum albumin (BSA), and phosphate 
buffer saline (PBS) tablets were purchased from Sigma- 
Aldrich  St.  Louis,  MO,  USA.  Ellman's  reagent  (5-5'-
dithiobis-(2-nitrobenzoic  acid;  DTNB),  NADPH, 
reductase,  scavenger,  glutathione  standard,  meta 
phosphoric acid, and assay buffer provided by a Reduced/ 
Oxidized  Glutathione  Cuvette  Assay  kit  #  GSH39-K01 
purchased  from  Eagle  Biosciences  Inc.,  Boston,  USA. 
Other chemicals were commercially available. 
 
Animals 
Male  Sprague–Dawley  rats  aging  three  to  four  months 
were  obtained  from  Animal  Care  Center  of  Shiraz 
University of Medical Sciences. The rats were housed two 
per cage under controlled (12 h/12 h) light/dark cycle and 
constant temperature of 242 °C; they had free access to 
food and water. All experiments were carried out during 
the light phase and in accordance to the guideline of the 
animal ethics committee of Shiraz University of Medical 
Sciences. 
 
Drug treatments 
The  rats  were  randomly  divided  into  four  groups 
containing  nine  animals  each.  Test  groups  received 
perindopril (Coversyl®, Servier, Cedex, France) at a dose 
of  1,  2  or  4  mg/kg/ml.  Control  group  received  normal 
saline at the same volume. Drugs were administered orally 
via  an  intragastric  gavage  tube  once  daily  for  four 
consecutive weeks.  
 
Tissue preparation 
The rats were decapitated under light ether anesthesia. The 
skull  was  cut  open  and  the  whole  brain  was  quickly 
removed.  The  hippocampi  were  dissected  and  cleaned 
with chilled normal  saline on the  ice, frozen quickly  in 
liquid  nitrogen  and  stored  separately  under  -70  °C  for 
future use.  
 
Biochemical assay 
Estimation of malondialdehyde (MDA) and protein 
One  of  the  right  or  left  hippocampus  of  each  rat  was 
selected randomly (n=9) and homogenized in 10% (w/v) 
of  PBS  (pH  7.4)  with  an  ultrasonic  homogenizer 
(BANDELIN, Sonoplus, Berlin) for 20 seconds with 3/2 
seconds on/off periods. The homogenate was centrifuged 
at 10000 g for 20 min at 4°C and the supernatant was used 
for  the  measurement  of  MDA  and  protein.  The 
concentration of protein in the supernatant was measured 
by  spectrophotometer  at  595  nm  by  the  Coomassie 
brilliant blue G-250 dye-binding technique of Bradford
14 
using serial dilution of BSA (1mg/1ml) as standard.  
MDA  as  a  marker  of  lipid  peroxidation  was  estimated 
according  to  its  reaction  with  TBA  as  a  TBA  reactive 
substance
15  with  modification.  Briefly,  0.5  ml  of  the 
supernatant was added to 2 ml TBA reagent containing 
0.375%  TBA,  15%  TCA  and  0.25  mol/L  HCl.  The 
mixture was boiled in a water bath at 95°C for 30 minutes 
and after fast cooling it was centrifuged at 8000 g for 15 
min at 4C. The absorbance of the pink color supernatant 
was  measured  at  532  nm.  MDA  concentration  was 
calculated  using  TEP  as  standard  and  expressed  as 
nmol/mg protein. 
 
Glutathione analyses 
The second hippocampus of the corresponding rat (n=7) 
was weighed precisely and homogenized the same way as 
that for MDA. The reduced and the oxidized glutathione 
content,  GSH  and  GSSG  respectively,  and  the  ratio  of 
GSH  to  GSSG  were  measured  according  to  an  eagle 
bioscience  GSH/GSSG  cuvette  assay  kit.  Briefly,  two 
samples  were  prepared  from  the  homogenate,  one  for 
GSH  and  the  second  mixed  with  scavenger  for  GSSG 
assessment. After protein denaturation by metaphosphoric 
acid,  the  samples  were  centrifuged  at  10000  g  for  10 
minutes at 4°C and the supernatant was diluted with assay 
buffer.  The  samples  were  then  mixed  with  DTNB, 
reductase and NADPH at equal volumes (200µL) to yield 
a  yellowish  color  as  a  result  of  thiol-DTNB  enzymatic 
reaction. The absorbance was measured kinetically at 412 
nm  for  5  minutes.  The  glutathione  concentrations  were 
calculated using GSH and GSSG standard curves and the 
ratio  of  GSH/GSSG  was  calculated  by  (GSH-
2*GSSG)/GSSG  equation.  All  reagents  and  formulas 
were provided by the kit. The results were expressed as 
µmol/ gram wet tissue. 
 
Data analysis 
All statistical analyses were performed by SPSS version 
15. Data were presented as mean SEM. Because of the 
normal  distribution  of  data  confirmed  by  Kolmogrov 
Esmirnov  test;  comparisons  between  the  studied  groups 
were made using one way ANOVA followed by Tukey’s 
post hoc test. The P values less than 0.05 were considered 
as significant. 
 
Results 
Table 1 shows the results of GSH and GSSG analyses in 
the hippocampus of perindopril and normal saline treated 
rats.  The  data  indicate  that  treatment  of  rats  with 
perindopril  induced  enhancement  of  GSH  in  a  dose 
dependent manner [F (3, 24) = 4.34 P=0.014] that was 
significantly  about  66.6  %  higher  (p<0.01)  in  2  mg/kg 
perindopril treated group in comparison to the control rats.  
 
Table  1.  Effect  of  normal  saline  (N/S)  or  perindopril  (P)  on 
GSH and GSSG 
Treatments  GSH(µMol/mg tissue)  GSSG(µMol/mg tissue) 
N/S as control  1.8±0.2  0.04±0.004 
P 1 mg/kg  2.5±0.2  0.04±0.005 
P 2 mg/kg  3±0.25*  0.035±0.003 
P 4 mg/kg  2.6±0.25  0.04±0.005 
Effect of perindopril (P 1, 2, 4 mg/kg/day orally) compared to 
normal  saline  (N/S)  as  controlon  GSH  and  GSSG  (n=  7). 
Results are expressed as mean± SEM and data were analyzed 
by  one  way  ANOVA  followed  by  Tukey  multiple  comparison 
test. * Significantly different from the control, p<0.05  
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On the other hand the data in Table 1 demonstrate that 
the GSSG level remained unchanged in all groups as 
compared  to  the  control  groups  [F  (3,24)=  0.74 
P=0.538].  Therefore  the  GSH/GSSG  ratio  showed  a 
significant  increase  [F  (3,24)  =  3.16  P=0.043]  as  an 
antioxidant marker and this ratio was higher in 2 mg/kg 
perindopril  treated  group,  showing  82.8  % 
enhancement  as  compared  to  the  control  group 
(P<0.05) as shown in Figure 1. 
 
 
Figure  1.  Effect  of  perindopril  (P  1,  2,  4  mg/kg/day  orally) 
compared  to  normal  saline  (N/S)  as  control  on  GSH/GSSG 
ratio (n= 7). Results are expressed as mean± SEM and data 
were analyzed by one way ANOVA followed by Tukey multiple 
comparison  test.  #  Significantly  different  from  the  control, 
p<0.05 
 
The  data  in  Figure  2  demonstrate  that  treatment  of 
normal rats with perindopril recorded an insignificant 
reduction  in  brain  MDA  level  [F  (3,  30)  =  1.693, 
P=0.19] from 2.6±0.5 in control group to 1.7±0.2 in 1 
mg/kg  perindopril  treated  group.  However  the  MDA 
level rises again, although not significant, to 2.9±0.4 in 
4 mg/kg perindopril treated group. 
 
 
Figure  2.  Effect  of  perindopril  (P  1,  2,  4  mg/kg/day  orally) 
compared to normal saline (N/S) as control on MDA (n=8-9). 
Results are expressed as mean± SEM and data were analyzed 
by  one  way  ANOVA  followed  by  Tukey multiple comparison 
test. 
 
Discussion 
In  the  present  study  GSH  and  GSH/GSSG  ratio 
increased  dose  dependently  in  the  hippocampus  of 
perindopril treated groups. Brain is a susceptible organ 
to  oxidative  stress  due  to  high  metabolic  rate,  high 
poly-unsaturated  fatty  acids  and  low  antioxidant 
demand.
16  To  combat  with  oxidative  conditions  the 
cells  are  provided  with  several  antioxidants  such  as 
GSH  which  is  a  major  and  strong  intracellular 
antioxidant.  GSH  acts  as  a  donor  of  electron  to  free 
radicals, giving rise to GSSG which then reduced and 
recycled again to GSH through enzymatic reactions.
17 
GSH  also  acts  as  a  scavenger  of  reactive  oxygen 
species  (ROS)  and  an  inhibitor  of  H2O2-induced 
hydroxyl  radical  formation.  Thereby,  GSH  and  the 
GSH/GSSG  ratio  levels  determine  the  defensive 
potency of the cells against oxidative stress in tissues 
like the brain.
18 
The glutathione analysis technique in this study support 
directly  analysis  of  both  reduced  and  oxidized 
glutathione.  Previous  studies  showed  that  the 
inappropriate changes of total or oxidized glutathione 
recovered  by  ACE  inhibitors  such  as  ramipril  or 
captopril  in  the  experimentally  models  of  oxidative 
damages.
12,19 In our study although perindopril did not 
exert  any  beneficial  effect  on  physiologic  amount  of 
GSSG, but it suggested that even physiologic amounts 
of GSH, the reduced form, may increase in response to 
ACE  inhibitors.  In  the  current  study,  all  of  the 
perindopril –treated groups showed higher amounts of 
GSH and GSH/GSSG ratio. However, a significant rise 
was  only  seen  in  2  mg/kg  perindopril-treated  group 
indicating  that  there  might  be  an  optimum  dose  for 
perindopril  to  effectively  cause  an  increase  in  the 
reduced glutathione level.  
An  insignificant  decrease  was  observed  in  MDA 
analysis which was recovered as the dose of perindopril 
increased. MDA, a by-product of lipid peroxidation, is 
a major biomarker of the membrane lipid peroxidation 
by  excessive  ROS  in  the  brain  tissue  that  composes 
high  poly  unsaturated  fatty  acids.
16  In  the  oxidative 
condition induced by chronic cerebral hypoperfusion in 
rats,  the  elevated  MDA  decreased  after  captopril 
treatment.
11  In  the  present  study  there  was  also  a 
tendency  for  MDA  to  be  lessened  in  1  mg/kg 
perindopril  treated  group.  MDA  then  increased 
progressively to a higher level than control in 4 mg/kg 
perindopril  treated  group,  indicating  a  probable  dual 
action  of  perindopril:  the  antioxidant  effects  at  low 
doses  and  oxidative  effects  at  high  doses.  The 
insignificant  decrease  in  GSH  level  in  4  mg/kg 
perindopril  treated  group,  in  accordance  with 
enhancement  of  MDA  level  at  4  mg//kg  perindopril 
treated  group,  also  may  result  from  conversion  of 
benefit  to  toxic  effects  of  perindopril  through 
increasing the dose that should be confirmed by further 
studies.  
In another point of view, the insignificant alteration in 
MDA and GSSG in this study may also indicate first: 
under  physiologic  condition,  the  basal  lipid 
peroxidation may be continued normally and might not 
be  changed  prominently  by  perindopril.  Second:  the  
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increase of reduced glutathione may not be the outcome 
of a compensatory response to increased free radicals 
as  indicated  previously,
20  but  it  is  potentially  an 
improvement  in  anti-oxidant  defense  in  response  to 
perindopril. This may strengthen the antioxidant pool 
of  the  tissues  like  the  brain  as  a  sensitive  organ  to 
oxidative stress. 
The main mechanism by which perindopril caused the 
increase of reduced glutathione in this study might be 
the inhibition of ACE. Hippocampus is a large structure 
in the brain and involved in advanced brain functions 
like  learning  and  memory.
21  It  has  been  found  to 
possess  all  of  the  renin-angiotensin  components 
including ACE, which is abundant both in the vessels 
and  neuronal  cells,  its  active  product,  angiotensin  II, 
and all of the angiotensin receptors.
22 Perindopril is a 
lipophilic  brain  penetrating  ACE  inhibitor  with  an 
effective potency of ACE inhibition in structures like 
hippocampus. In this study we used the similar doses of 
perindopril which have been demonstrated previously 
to inhibit more than 50% of hippocampal ACE.
10,23 
ACE  inhibition  by  perindopril  in  turn  leads  to 
attenuation  of  Ang  II  formation  and  AT1  receptor 
expression.
11  Ang  II  through  stimulation  of  AT1 
receptor  exerts  its  potent  vasoconstrictory  activity.
7 
Circulatory  disturbance,  as  seen  in  hypo-perfusion  or 
ischemia reperfusion, resulted in severe oxidative stress 
in several tissues as well as the brain.
12,24,25 Therefore, 
ACE  inhibition  may  lead  to  better  circulation  and 
prevent  minor  oxidative  stresses  caused  by  transient 
vasoconstrictions that  may happen  during normal  life 
or probably during one month treating with perindopril 
in this study. Attenuation of AngⅡ by ACE inhibition, 
additionally,  may  diminish  the  activation  of  NADPH 
oxidase
26 which is a pivotal enzyme in the production 
of free radicals.
27 ACE inhibitors were also evidenced 
to directly act as a scavenger of free radicals.
28,29 All 
these  mechanisms  may  lower  the  amount  of  free 
radicals and the consequent GSH consumption. On the 
other hand, ACE inhibitors was found to augment the 
activity  of  glutathione  reductase,  the  enzyme  that 
catalyze recycling of GSSG to GSH
19 and may result in 
more GSH production. Further studies should address 
this  issue  and  also  the  probable  effect  of  ACE 
inhibitors on the activity of the enzymes that catalyze 
GSH synthesis reactions and/ or intestinal absorption of 
GSH which are other GSH supplementary pathways.
30 
 
Conclusion 
This study reports that ACE inhibition can improve the 
cellular  anti-oxidant  defense  and  may  suggest  ACE 
inhibitors,  especially  those  that  penetrate  blood-brain 
barrier,  as  worthy  drugs  for  prevention  of  neural 
damages induced by oxidative stress. 
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